The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients
- PMID:16961788
- DOI: 10.1111/j.1468-2982.2006.01195.x
The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients
Abstract
Migraine attacks are often preceded by premonitory symptoms. Prevalence rates of migraine patients reporting one or more premonitory symptoms show considerable variability and rates range between 12% and 79%. Sources of variability might be differences in study population or research design. Using a questionnaire, we retrospectively studied the prevalence of 12 predefined premonitory symptoms in a clinic-based population. Of 461 migraine patients, 374 (81%) responded. At least one premonitory symptom was reported by 86.9% and 71.1% reported two or more. The most frequently reported premonitory symptoms were fatigue (46.5%), phonophobia (36.4%) and yawning (35.8%). The mean number of premonitory symptoms per person was 3.2 (+/- 2.5). Women reported 3.3 premonitory symptoms compared with 2.5 symptoms in men (P = 0.01). Age, education, migraine subtype (with or without aura) and mean attack frequency had no effect on the mean number of symptoms per individual. In conclusion, premonitory symptoms are frequently reported by migraine patients. Sensitivity and specificity of premonitory symptoms for migraine need to be assessed using prospective methods.
Similar articles
- The prevalence of premonitory symptoms in paediatric migraine: a questionnaire study in 103 children and adolescents.Cuvellier JC, Mars A, Vallée L.Cuvellier JC, et al.Cephalalgia. 2009 Nov;29(11):1197-201. doi: 10.1111/j.1468-2982.2009.01854.x.Cephalalgia. 2009.PMID:19811504
- Premonitory symptoms in migraine from China: A multi-clinic study of 4821 patients.Wang X, Yin Z, Lian Y, Xu Y, Li Y, Liu J, Gu Q, Yan F, Ge Z, Lian Y, Hu D, Chen S, Wang R, Chen X, Liu J, Zhang M, Ran Y, Zhou P, Ma J, Lv X, Dong Z, Yu S.Wang X, et al.Cephalalgia. 2021 Aug;41(9):991-1003. doi: 10.1177/0333102421997850. Epub 2021 Feb 25.Cephalalgia. 2021.PMID:33631964
- The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs.Kelman L.Kelman L.Headache. 2004 Oct;44(9):865-72. doi: 10.1111/j.1526-4610.2004.04168.x.Headache. 2004.PMID:15447695
- Prodromes and the early phase of the migraine attack: therapeutic relevance.Buzzi MG, Cologno D, Formisano R, Rossi P.Buzzi MG, et al.Funct Neurol. 2005 Oct-Dec;20(4):179-83.Funct Neurol. 2005.PMID:16483458Review.
- The premonitory phase of migraine and migraine management.Becker WJ.Becker WJ.Cephalalgia. 2013 Oct;33(13):1117-21. doi: 10.1177/0333102412437390. Epub 2012 Feb 15.Cephalalgia. 2013.PMID:22337860Review.
Cited by
- Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.Lipton RB, Lanteri-Minet M, Leroux E, Manack Adams A, Contreras-De Lama J, Reed ML, Fanning KM, Buse DC.Lipton RB, et al.J Headache Pain. 2023 Nov 8;24(1):151. doi: 10.1186/s10194-023-01683-1.J Headache Pain. 2023.PMID:37940856Free PMC article.
- Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service.Karsan N, Prabhakar P, Goadsby PJ.Karsan N, et al.J Headache Pain. 2016 Dec;17(1):94. doi: 10.1186/s10194-016-0689-7. Epub 2016 Oct 21.J Headache Pain. 2016.PMID:27770403Free PMC article.
- ASICs as therapeutic targets for migraine.Dussor G.Dussor G.Neuropharmacology. 2015 Jul;94:64-71. doi: 10.1016/j.neuropharm.2014.12.015. Epub 2015 Jan 9.Neuropharmacology. 2015.PMID:25582295Free PMC article.Review.
- FGF-21 and GDF-15 are increased in migraine and associated with the severity of migraine-related disability.He J, Zhou M, Zhao F, Cheng H, Huang H, Xu X, Han J, Hong W, Wang F, Xiao Y, Xia J, Liu K.He J, et al.J Headache Pain. 2023 Mar 20;24(1):28. doi: 10.1186/s10194-023-01563-8.J Headache Pain. 2023.PMID:36935492Free PMC article.
- To what extent are patients with migraine able to predict attacks?Gago-Veiga AB, Pagán J, Henares K, Heredia P, González-García N, De Orbe MI, Ayala JL, Sobrado M, Vivancos J.Gago-Veiga AB, et al.J Pain Res. 2018 Sep 27;11:2083-2094. doi: 10.2147/JPR.S175602. eCollection 2018.J Pain Res. 2018.PMID:30310310Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous